Explorer
Coronavirus third wave 'dangerous' for kids, vaccine trial approved
Bharat Biotech International Ltd (BBIL) had proposed to carry out a Phase II-III clinical trial of Covaxin in the age group of two to 18 years.
As rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (Covid-19) on May 11 this year. Coronavirus' third wave can be 'dangerous' for kids, so the necessary steps are being taken care of
India
PARLIAMENT DEADLOCK: Opposition Stands Firm on Education Minister’s Resignation Before Discussion
Politics: Opposition Targets PM Modi Over Silence on Student Protest
Maharashtra Politics: Uddhav-Raj Thackeray Target Government Over Student Protests, Announce Mega March
BJP vs Opposition: NEET Row Escalates in Parliament as Opposition Demands Education Minister’s Resignation
Parliament NEET Row: BJP Accuses Congress of Avoiding NEET Debate, Highlights Fast-Track Court Decision
View More
Trending News




















